基于主题建模和知识图的技术进化和在药房应用人工智能的热点识别
Zhijing Zhang1, Ying Wang1, Tong Wu1
1School of Business and Administration, Shenyang Pharmaceutical University, Shenyang, China.
Current pharmaceutical biotechnology
|October 22, 2025
概括
人工智能 (AI) 正在改变制药行业,专利迅速增长,研究重点关注整个药物生命周期. 未来的创新包括精准医学和可解释的AI (XAI) 用于增强的药房建模.
科学领域:
- 制药科学 制药科学
- 计算机科学 计算机科学
- 数据科学数据科学数据科学
背景情况:
- 人工智能 (AI) 的采用正在整个制药行业的价值链中加速.
- 虽然人工智能提供了提高效率和降低成本,但其集成带来了独特的挑战.
- 本研究探讨了人工智能在药学中的技术进化和当前创新热点.
研究的目的:
- 分析AI在制药行业的技术发展.
- 在药房内识别人工智能应用中的当代创新热点.
- 为未来的技术发展方向提供洞察力.
主要方法:
- 采用了多源数据融合分析方法.
- 分析了获得专利的发明 (1990-2024) 和研究文章 (2020-2024).
- 隐性迪里克莱特分配 (LDA) 主题建模和CiteSpace知识图表构建被用于数据分析.
主要成果:
- 在过去的五年中,观察到与人工智能相关的药品专利大幅增加.
- 在AI技术主题中确定了明显的进化趋势.
- 研究热点涵盖整个制药生命周期,从药物发现到临床交付.
结论:
- 药品中关键的人工智能应用热点包括目标识别,虚拟查,药物输送,临床试验和药物监测.
- 精准医学和可解释的人工智能 (XAI) 驱动的药房建模正在成为未来发展的关键领域.
- 人工智能正在从根本上重塑制药行业,预计将推动未来的重大创新.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Current Trends in Nursing II
3.3K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
240
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
240
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K


